African Programme for Onchocerciasis Control (APOC)

Chad

Onchocerciasis status

In Chad, the onchocerciasis focus is located in the southern part of the country.

Rapid epidemiological mapping of onchocerciasis in Chad, showing areas (in red) where community-directed treatment with ivermectin is needed

This map is an approximation of actual country borders.

People affected by onchocerciasis

  • Number of communities in meso/hyper endemic (red) areas (2006): 3250
  • Total population in meso/hyper endemic (red) areas (2006): 1 646 902

Projects

  • Number of current community-directed treatment with ivermectin (CDTI) projects (2007): 1
  • Date first community-directed treatment with ivermectin (CDTI) project was launched: 1998
  • Number of national onchocerciasis task force (NOTF)-secretariat supported projects: 0
  • Number of vector elimination projects: 0

NOTF-secretariat supported project is based at national level and is responsible for overseeing the implementation of all CDTI projects in the country and ensuring the availability of ivermectin.

Ivermectin coverage

Geographical coverage (2007)
  • Number of communities treated with ivermectin: 3250
  • Treatment target (number of communities): 3250
  • Geographic coverage: 100%
Therapeutic coverage (2007)
  • Number of people treated with ivermectin: 1 389 921
  • Treatment target (number of people): 1 699 561
  • Therapeutic coverage: 81.8%

Training

  • Number of trained or retrained community-directed distributors, CDDs (2007): 2 732
  • Number of people per community-directed distributor, CDD (2007): 622
  • Number of trained or retrained health workers (2007): 201

Funds

Projects are funded from three primary sources:

  • the APOC Trust Fund
  • the government of the country where the projects are being implemented
  • funds from non-governmental development organization partners.

Related links